课题基金 / 基金详情

Field-induced pores formation during iontophoresis

Field-induced pores formation during iontophoresis
离子电渗疗法过程中场诱导的孔隙形成
批准号:
6620281
负责人:
Jagdish Singh
金额:
$7.05万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-01 至 2005-03-31

项目摘要

项目成果

Jagdish Singh的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term objective of the proposed research is to understand the mechanism of alteration in skin barrier properties by iontophoresis in order to develop transdermal drug delivery systems for macromolecules, including polypeptide hormones. Initiation of current flow across the skin causes a rapid decrease in resistance of the membrane to achieve a new lower value. Voltage-induced effects, which decrease the electrical resistance and proportionally increase the flux of both ionic permeants and polar, non-ionic solutes, suggest that these effects are primarily electric field induced pore formation. However, physical presence of electric field induced pores in the HSC has not been demonstrated. The overall hypothesis to be evaluated is that skin resistance changes are due to ions in the media changing the number of ions in the skin and formation of pores during iontophoresis. To test these hypotheses, we propose studies with the following Specific Aims: 1) To determine the effect of a constant D.C. voltage (200-10,000 mV), concentration, and type of electrolytes on the resistance (conductivity) of the HSC; 2a) To characterize topographical (structural) changes in the HSC in real time at sub-micrometer to nanometer levels using AFM; and 2b) to determine the number and size of field-induced pores per unit surface area during iontophoresis using AFM. We believe that the proposed research will significantly enhance our basic understanding about alterations in skin by iontophoresis for non-invasive delivery of macromolecules, including polypeptide hormones such as human growth hormone and insulin.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.ijpharm.2007.03.054
发表时间: 2007-08
期刊: International journal of pharmaceutics
影响因子: 5.8
作者: [Somnath Singh;D. Webster;Jagdish Singh]
通讯作者: Somnath Singh;D. Webster;Jagdish Singh
Phase-sensitive polymer-based controlled delivery systems of leuprolide acetate: in vitro release, biocompatibility, and in vivo absorption in rabbits.
基于相敏聚合物的醋酸亮丙瑞林控释系统:体外释放、生物相容性和兔子体内吸收。
DOI: 10.1016/j.ijpharm.2006.07.051
发表时间: 2007
期刊: International journal of pharmaceutics
影响因子: 5.8
作者: [Singh,Somnath, Singh,Jagdish]
通讯作者: Singh,Jagdish
Skin targeted DNA vaccine delivery using electroporation in rabbits. I: efficacy.
使用电穿孔对兔子进行皮肤靶向 DNA 疫苗递送。
DOI: 10.1016/j.ijpharm.2004.12.014
发表时间: 2005
期刊: International journal of pharmaceutics.
影响因子: --
作者: [Medi,BabuM, Hoselton,Scott, Marepalli,RaoB, Singh,Jagdish]
通讯作者: Singh,Jagdish
Effect of chemical penetration enhancer and iontophoresis on the in vitro percutaneous absorption enhancement of insulin through porcine epidermis.
化学渗透促进剂和离子电渗疗法对猪表皮胰岛素体外经皮吸收增强的影响。
DOI: 10.1081/pdt-49679
发表时间: 2005
期刊: Pharmaceutical development and technology.
影响因子: --
作者: [Rastogi,SumeetK, Singh,Jagdish]
通讯作者: Singh,Jagdish
6
    Modification of insulin molecule for controlled delivery at basal level from triblock copolymers
    • 批准号:
      8876907
    • 项目类别:
    • 资助金额:
      $34.8万
    • 财政年份:
      2015
    • 负责人:
      Jagdish Singh
    • 依托单位:
    Controlled delivery of polypeptide hormone calcitonin
    • 批准号:
      8515282
    • 项目类别:
    • 资助金额:
      $6.85万
    • 财政年份:
      2012
    • 负责人:
      Jagdish Singh
    • 依托单位:
    Controlled delivery of polypeptide hormone calcitonin
    • 批准号:
      8382758
    • 项目类别:
    • 资助金额:
      $7.23万
    • 财政年份:
      2012
    • 负责人:
      Jagdish Singh
    • 依托单位:
    Prevention of diabetes by pDNA encoded with IL-10
    • 批准号:
      7915665
    • 项目类别:
    • 资助金额:
      $7.18万
    • 财政年份:
      2009
    • 负责人:
      Jagdish Singh
    • 依托单位:
    海外基金